Review
doi: 10.1159/000057366.
TGF-beta in glomerular disease
Affiliations
- PMID: 9525701
- DOI: 10.1159/000057366
Item in Clipboard
Review
TGF-beta in glomerular disease
Miner Electrolyte Metab.
1998.
Abstract
Transforming growth factor-beta (TGF-beta) is an important cytokine in glomerular disease. Its major role may be to mediate extracellular matrix deposition, by both increasing the synthesis of matrix components and by reducing their degradation. Strong evidence supports the functional role for TGF-beta in mesangial matrix expansion. However, TGF-beta may also have other important functions in the glomerulus, including the regulation of cell proliferation, hypertrophy, and survival (apoptosis), as well as modulation of the local and systemic immune response.
Similar articles
-
Glomerular hypertension and progressive renal disease: the interplay of mesangial cell stretch, cytokine formation and extracellular matrix synthesis.Contrib Nephrol. 1996;118:229-33. doi: 10.1159/000425098. Contrib Nephrol. 1996. PMID: 8744062 Review. No abstract available.
-
Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.Cell Differ Dev. 1990 Dec 2;32(3):425-31. doi: 10.1016/0922-3371(90)90059-6. Cell Differ Dev. 1990. PMID: 2099240 Review.
-
Escherichia coli-macrophage interactions modulate mesangial cell proliferation and matrix synthesis.Nephron. 1996;73(4):587-96. doi: 10.1159/000189145. Nephron. 1996. PMID: 8856256
-
Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta.Am J Pathol. 1995 Aug;147(2):375-85. Am J Pathol. 1995. PMID: 7639331 Free PMC article.
-
Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease.Histol Histopathol. 2009 Jul;24(7):901-8. doi: 10.14670/HH-24.901. Histol Histopathol. 2009. PMID: 19475536 Review.
Cited by
-
Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.J Mol Med (Berl). 2003 Jan;81(1):32-42. doi: 10.1007/s00109-002-0403-x. Epub 2002 Dec 14. J Mol Med (Berl). 2003. PMID: 12545247
-
Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.PLoS One. 2018 Apr 11;13(4):e0195779. doi: 10.1371/journal.pone.0195779. eCollection 2018. PLoS One. 2018. PMID: 29641565 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical